AMERICAN FORK, Dec. 13, 2018 - American Silver, LLC, parent company to American Biotech Labs, LLC "ABL" has declared a $0.33 per share distribution, providing approximately $500,000 to Clifton Mining Company, its largest single shareholder. Together with the distribution of $0.10 issued earlier this year, Clifton has received distributions totaling approximately $655,000 for 2018. This is the largest total annual amount distributed by American Silver in its history and reflects healthy growth in the demand for the array of its patented silver Nano-particle anti-pathogenic products (see www.silverbiotics.com).
Much of ABL's success in 2018 has come from the addition of new distributors of its products including Walmart stores and others. ABL's wound dressing gel product Armor Gel™, is now being sold in a number of new stores including Rite Aid, Harmons, Bed Bath & Beyond, Wakefern, Walgreens, Supervalu, and Big Y. Management of ABL is hopeful for continued robust growth. Said Keith Moeller, VP, "Our strategic investment in American Silver has helped to provide Clifton with valuable income even when gold/silver prices have been declining. We believe American Silver will become even more significant to Clifton's bottom line in the future."
Please see the Company's website www.cliftonmining.com for additional Company information. Clifton trades on the U.S. OTC: (CFTN).
Note: Any statements released by Clifton Mining Company that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward looking statements invoke risk and uncertainties that may affect the company's business prospects and performance.
Für den Inhalt des Beitrages ist allein der Autor verantwortlich bzw. die aufgeführte Quelle. Bild- oder Filmrechte liegen beim Autor/Quelle bzw. bei der vom ihm benannten Quelle. Bei Übersetzungen können Fehler nicht ausgeschlossen werden. Der vertretene Standpunkt eines Autors spiegelt generell nicht die Meinung des Webseiten-Betreibers wieder. Mittels der Veröffentlichung will dieser lediglich ein pluralistisches Meinungsbild darstellen. Direkte oder indirekte Aussagen in einem Beitrag stellen keinerlei Aufforderung zum Kauf-/Verkauf von Wertpapieren dar. Wir wehren uns gegen jede Form von Hass, Diskriminierung und Verletzung der Menschenwürde. Beachten Sie bitte auch unsere AGB/Disclaimer!